U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Show Filters
Hide Filters
Development Status
US Approved Rx
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Approval Year
2009
1
2017
1
2018
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Class
Protein
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Code System
CAS
3
ChEMBL
3
DAILYMED
3
DRUG BANK
3
DRUG CENTRAL
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Protein Type
MONOCLONAL ANTIBODY
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 1
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 2
IMMUNOSUPPRESSANTS
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 3
IMMUNOSUPPRESSANTS
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 4
Interleukin inhibitors
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Form
Principal Form
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Search results for
"Established Pharmacologic Class [EPC]|Interleukin-23 Antagonist [EPC]"
in
comments
(approximate match)
Showing
1 - 3
of
3
results
Search within data set
First page disabled
Previous page disabled
1
Next page disabled
Next page disabled
Sort By
Approval Year, Recent
Approval Year, Oldest
Relevance
Display Name, A-Z
Display Name, Z-A
Least References
Most References
Oldest Change
Newest Change
TILDRAKIZUMAB
MORE DETAILS
DEW6X41BEK
Subunit
1
(446) Similarity Search
Subunit
2
(446) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Export Data
Sequence Search
Subunit
1
(446) Similarity Search
Subunit
2
(446) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Status:
US Approved Rx (2018)
First approved in 2018
Class:
PROTEIN
GUSELKUMAB
MORE DETAILS
089658A12D
Subunit
1
(446) Similarity Search
Subunit
2
(446) Similarity Search
Subunit
3
(217) Similarity Search
Subunit
4
(217) Similarity Search
Export Data
Sequence Search
Subunit
1
(446) Similarity Search
Subunit
2
(446) Similarity Search
Subunit
3
(217) Similarity Search
Subunit
4
(217) Similarity Search
Status:
US Approved Rx (2017)
First approved in 2017
Class:
PROTEIN
USTEKINUMAB
MORE DETAILS
FU77B4U5Z0
Subunit
1
(449) Similarity Search
Subunit
2
(449) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Export Data
Sequence Search
Subunit
1
(449) Similarity Search
Subunit
2
(449) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Status:
US Approved Rx (2024)
First approved in 2009
Class:
PROTEIN
